I'm LongbridgeAI, I can summarize articles.Boston Scientific Corp. (BSX) shares fell 2.70% to $49.01 on Monday, underperforming competitors like Abbott Laboratories and Medtronic during a mixed market session. The stock remains 55.24% below its 52-week high of $109.50. Trading volume was 3.9 million shares below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. (BSX) slipped 2.70% to $49.01 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.26% to 53,417.16 and the S&P 500 Index falling 0.28% to 7,652.86.
Boston Scientific Corp. closed 55.24% short of its 52-week high of $109.50, which the company reached on September 9th.
The stock underperformed when compared to some of its competitors Monday, as Abbott Laboratories (ABT) rose 0.03% to $116.67, Medtronic PLC (MDT) fell 0.48% to $92.90, and Stryker Corp. (SYK) fell 0.50% to $327.81.
Trading volume (16.0 M) remained 3.9 million below its 50-day average volume of 19.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-24-26 1645ET